Medical Information Only. Consult your healthcare provider before considering clinical trial enrollment.

ClinicalTrials.gov 6 recruiting now early-phase tilt small index

Diabetes Complications: early-phase trial registry

6 of 11 indexed Diabetes Complications trials are currently recruiting, with more weight in Phase 1-2.

Corpus placement: #1,577 of 28,707 conditions by registered trial count.

11 US clinical trials · 6 currently recruiting · #1,577 of 28,707 conditions by registered trial count

Diabetes Complications: 11 US clinical trials tracked, 6 recruiting.

Diabetes Complications is the subject of 11 registered US clinical trials on ClinicalTrials.gov, 6 of them currently open to new participants. 1 are in Phase 3-4 (later-stage) and 4 in Phase 1-2 (earlier-stage). The most active sponsor is University of Colorado, Denver, running 3 of these trials.

Enrollment posture brief

Registry condition diabetes-complications

OPEN 6 | RECR 55% | LATE 1 | EARLY 4 | RANK #1577 | SPON 3

Nearest open-share peer: Advanced Ovarian Carcinoma (55% recruiting · 11 trials)

Acute Pancreatitis81.8%Diabetes Complications (this)55%Acute Stroke45.5%Acquired Brain Injury36.4%Acute Lung Injury9.1%
Open-enrollment share among volume-matched conditions near Diabetes Complications

Diabetes Complications lists 6 open slots (55% of 11 indexed trials). Peers are matched on registered volume, not therapeutic-area browse lists. How peer matching works →

Key findings

What ClinicalTrials.gov does not surface for Diabetes Complications on its own pages , computed from the registry mirror as of 2026-08-08. Each line carries its own denominator so it can be quoted as it stands.

  1. Diabetes Complications is recruiting above its size-band peers.

    6 of 11 indexed trials (54.5%) are open to enrollment, against a 46.5% average across 27,806 conditions with fewer than 20 trials. The peer set uses the same ClinicalTrials.gov-derived counts as this page.

  2. One sponsor concentrates Diabetes Complications research.

    University of Colorado, Denver accounts for 3 of 11 trials (27.3%). 9 distinct sponsors appear on at least one study for this condition label.

  3. Typical Diabetes Complications enrolment sits around 60 participants.

    Median target enrolment is 60 among the 11 trials that report a genuine target (sentinel values excluded). 6 of those (54.5%) plan for fewer than 100 participants.

  4. Diabetes Complications research is mostly interventional.

    9 interventional and 2 observational studies make up this index (81.8% interventional). Study type is sponsor-reported on ClinicalTrials.gov.

Phase 13Phase 21Phase 31

Open and recent trials

11 total, page 1 of 1

RECRUITING Phase 1 5,000 participants

Mesenchymal Stem Cells for the Treatment of Various Chronic and Acute Conditions

Thomas Advanced Medical

NCT04684602

RECRUITING NA 140 participants

Hybrid Closed Loop Effectiveness Trial in Adults With Type 1 Diabetes

Boston Medical Center

NCT06236607

RECRUITING NA 120 participants

Feasibility and Effectiveness of a Remote Monitoring Program for the Treatment of Diabetic Foot Ulcers

Johns Hopkins University

NCT05579743

RECRUITING NA 120 participants

A Fruit and Vegetable Prescription Program

Milton S. Hershey Medical Center

NCT06107816

RECRUITING 100 participants

Pathogenesis of Kidney Disease in Type 1 Diabetes: a Modern Kidney Biopsy Cohort (The PANDA Study)

University of Colorado, Denver

NCT05319990

RECRUITING 20 participants

Human iPSC for Repair of Vasodegenerative Vessels in Diabetic Retinopathy

University of Alabama at Birmingham

NCT03403699

ACTIVE NOT RECRUITING NA 60 participants

Electronic Diabetes Tune-Up Group (eDTU) for African Americans

Indiana University

NCT06321029

COMPLETED Phase 1 39 participants

First-In-Human Study of GFB-024 in Healthy Overweight and Obese Participants, and Participants With Type 2 Diabetes

Goldfinch Bio

NCT04880291

COMPLETED Phase 1 24 participants

Impact of Metabolic Surgery on Pancreatic, Renal and Cardiovascular Health in Youth With Type 2 Diabetes

University of Colorado, Denver

NCT03620773

COMPLETED Phase 3 16 participants

A Pilot Intervention Study of Health Coaching to Promote Diabetes Self-Care in the Community

Northwestern University

NCT01695278

COMPLETED Phase 2 10 participants

Evaluation of Coffee Therapy for Improvement of Renal Oxygenation

University of Colorado, Denver

NCT03878277

Phase Distribution

PhaseTrial count
Phase 1 3
Phase 2 1
Phase 3 1

Named interventions

Most-linked intervention names on Diabetes Complications records (sponsor-reported on ClinicalTrials.gov). Counts are trial links, not unique products.

GFB-024 Drug
1 trials
Telephone Counseling Behavioral
1 trials
Iohexol Inj 300 mg/mL Drug
1 trials
Renal Biopsy Procedure
1 trials
Starbucks® Cold brew - 325ml bottle Drug
1 trials
Diabetes Tune-Up Group Behavioral
1 trials
Vertical Sleeve Gastrectomy Procedure
1 trials
F&V Rx plus DSME/S Behavioral
1 trials

US sites by state

Facility locations filed on Diabetes Complications trials. A trial with sites in several states counts in each.

Colorado 3 trials
Texas 1 trials
Pennsylvania 1 trials
New York 1 trials
Maryland 1 trials
Massachusetts 1 trials
Indiana 1 trials
Illinois 1 trials

Source: ClinicalTrials.gov, National Library of Medicine. Data is informational only.

What to do with this Diabetes Complications page

11 registered trials, 6 currently recruiting, is a starting point for a conversation, not a diagnosis or a recommendation.

Trial and recruiting counts reflect ClinicalTrials.gov registry status as of the data vintage above; individual trial eligibility and enrollment status can change.

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This Diabetes Complications condition card totals 11 registered trials; most-linked intervention GFB-024; top US site state Colorado. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.